Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Bone marrow transplantation

Results: 1-25/1705

Authors: MEHTA J SINGHAL S
Citation: J. Mehta et S. Singhal, GRAFT-VERSUS-MYELOMA, Bone marrow transplantation, 22(9), 1998, pp. 835-843

Authors: CHARRIER S CHASSAGNE J CURE H BAY JO COMMUNAL Y PORTEFAIX G FERRIERE JP BETAIL G PLAGNE R CHOLLET P
Citation: S. Charrier et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AFTER INDUCTION CHEMOTHERAPY RUBICIN-VINORELBINE-CYCLOPHOSPHAMIDE-FLUOROURACIL) AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN BREAST-CANCER, Bone marrow transplantation, 22(9), 1998, pp. 845-851

Authors: LIE AKW HUI CH RAWLING T DYSON PG THORP D BENIC J RAWLING CM TOOGOOD I HORVATH N SIMMONS PJ TO LB
Citation: Akw. Lie et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) DOSE-DEPENDENT EFFICACYIN PERIPHERAL-BLOOD STEM-CELL MOBILIZATION IN PATIENTS WHO HAD FAILEDINITIAL MOBILIZATION WITH CHEMOTHERAPY AND G-CSF, Bone marrow transplantation, 22(9), 1998, pp. 853-857

Authors: CLARK RE BRAMMER CG
Citation: Re. Clark et Cg. Brammer, PREVIOUS TREATMENT PREDICTS THE EFFICIENCY OF BLOOD PROGENITOR-CELL MOBILIZATION - VALIDATION OF A CHEMOTHERAPY SCORING SYSTEM, Bone marrow transplantation, 22(9), 1998, pp. 859-863

Authors: LINKER CA RIES CA DAMON LE RUGO HS WOLF JL
Citation: Ca. Linker et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA USING 4-HYDROPEROXYCYCLOPHOSPHAMIDE-PURGED BONE-MARROW AND THE BUSULFAN ETOPOSIDE PREPARATIVE REGIMEN - A FOLLOW-UP REPORT/, Bone marrow transplantation, 22(9), 1998, pp. 865-872

Authors: SHERER Y SHOENFELD Y
Citation: Y. Sherer et Y. Shoenfeld, AUTOIMMUNE-DISEASES AND AUTOIMMUNITY POST-BONE MARROW TRANSPLANTATION, Bone marrow transplantation, 22(9), 1998, pp. 873-881

Authors: LEE JH LEE KH KIM S LEE JS KIM WK PARK CJ CHI HS KIM SH
Citation: Jh. Lee et al., RELEVANCE OF PROTEIN-C AND PROTEIN-S, ANTITHROMBIN-III, VON-WILLEBRAND-FACTOR, AND FACTOR-VIII FOR THE DEVELOPMENT OF HEPATIC VENOOCCLUSIVEDISEASE IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION- A PROSPECTIVE-STUDY, Bone marrow transplantation, 22(9), 1998, pp. 883-888

Authors: CHILDS R SANCHEZ C ENGLER H PREUSS J ROSENFELD S DUNBAR C VANRHEE F PLANTE M PHANG S BARRETT AJ
Citation: R. Childs et al., HIGH-INCIDENCE OF ADENOVIRUS-INDUCED AND POLYOMAVIRUS-INDUCED HEMORRHAGIC CYSTITIS IN BONE-MARROW ALLOTRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCY FOLLOWING T-CELL DEPLETION AND CYCLOSPORINE, Bone marrow transplantation, 22(9), 1998, pp. 889-893

Authors: RUFER N STAROBINSKI M CHAPUIS B GRATWOHL A JEANNET M HELG C ROOSNEK E
Citation: N. Rufer et al., CLINICAL CONSEQUENCES OF SENSITIZATION TO MINOR HISTOCOMPATIBILITY ANTIGENS BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(9), 1998, pp. 895-898

Authors: MANTEIGA R MARTINO R SUREDA A LABEAGA R BRUNET S SIERRA J RABELLA N
Citation: R. Manteiga et al., CYTOMEGALOVIRUS PP65 ANTIGENEMIA-GUIDED PREEMPTIVE TREATMENT WITH GANCICLOVIR AFTER ALLOGENEIC STEM TRANSPLANTATION - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 22(9), 1998, pp. 899-904

Authors: KEOGH F ORIORDAN J MCNAMARA C DUGGAN C MCCANN SR
Citation: F. Keogh et al., PSYCHOSOCIAL ADAPTATION OF PATIENTS AND FAMILIES FOLLOWING BONE-MARROW TRANSPLANTATION - A PROSPECTIVE, LONGITUDINAL-STUDY, Bone marrow transplantation, 22(9), 1998, pp. 905-911

Authors: HASSAN Z NILSSON C HASSAN M
Citation: Z. Hassan et al., LIPOSOMAL BUSULFAN - BIOAVAILABILITY AND EFFECT ON BONE-MARROW IN MICE, Bone marrow transplantation, 22(9), 1998, pp. 913-918

Authors: KOSTARIDOU S LADIS V KATTAMIS A LARAS A HADZIYANNIS SJ
Citation: S. Kostaridou et al., HBEAG-NEGATIVE HEPATITIS-B IN A PREVIOUSLY THALASSEMIC PATIENT DURINGIMMUNOSUPPRESSIVE THERAPY FOR CHRONIC GVHD, Bone marrow transplantation, 22(9), 1998, pp. 919-921

Authors: HIRAYAMA M AZUMA E KUMAMOTO T QI J KOBAYASHI M KOMADA Y INUI T MIYAKE M MUGISHIMA H HAMAZAKI M SAKURAI M
Citation: M. Hirayama et al., LATE-ONSET UNILATERAL RENAL DYSFUNCTION COMBINED WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND BRONCHIAL-ASTHMA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN A CHILD, Bone marrow transplantation, 22(9), 1998, pp. 923-926

Authors: MATSUMOTO T AMAMOTO N KONDOH T NAKAYAMA M TAKAYANAGI T TSUJI Y
Citation: T. Matsumoto et al., COMPLETE-TYPE DIGEORGE-SYNDROME TREATED BY BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(9), 1998, pp. 927-930

Authors: SUZUKI N KUDOH T MIZUE N WATANABE J IKEHATA M TATENO M OOGURO H CHIBA S
Citation: N. Suzuki et al., CMV RETINITIS AFTER CESSATION OF GANCICLOVIR THERAPY FOR CMV ANTIGENEMIA IN AN UNRELATED BMT RECIPIENT, Bone marrow transplantation, 22(9), 1998, pp. 931-932

Authors: SARRA J VIVANCOS P SOLA R GRANENA A
Citation: J. Sarra et al., MULTIPLE RISK-FACTORS FOR HIGH-DOSE CHEMOTHERAPY, Bone marrow transplantation, 22(9), 1998, pp. 933-933

Authors: SASTRY PSRK POWLES RL
Citation: Psrk. Sastry et Rl. Powles, THALIDOMIDE FOR CHRONIC GVHD, Bone marrow transplantation, 22(9), 1998, pp. 933-934

Authors: KAMI M OGAWA S MITANI K HIRAI H
Citation: M. Kami et al., THALIDOMIDE FOR CHRONIC GVHD - REPLY, Bone marrow transplantation, 22(9), 1998, pp. 934-934

Authors: VANCE E GEORGE S GUINAN EC WHEELER C ANTIN JH AMBROSINO DM MOLRINE DC
Citation: E. Vance et al., COMPARISON OF MULTIPLE IMMUNIZATION SCHEDULES FOR HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE AND TETANUS TOXOID VACCINES FOLLOWING BONE-MARROWTRANSPLANTATION, Bone marrow transplantation, 22(8), 1998, pp. 735-741

Authors: MONTAGNA D LOCATELLI F CALCATERRA V COMOLI P MORETTA A GIORGIANI G ZECCA M BONETTI F GIRALDI E RONDINI G MACCARIO R
Citation: D. Montagna et al., DOES THE EMERGENCE AND PERSISTENCE OF DONOR-DERIVED LEUKEMIA-REACTIVECYTOTOXIC T-LYMPHOCYTES PROTECT PATIENTS GIVEN AN ALLOGENEIC BMT FROMRECURRENCE - RESULTS OF A PRELIMINARY-STUDY, Bone marrow transplantation, 22(8), 1998, pp. 743-750

Authors: KANDA Y TANAKA Y SHIRAKAWA K YATOMI T NAKAMURA N KAMI M SAITO T IZUTSU K ASAI T YUJI K OGAWA S HONDA H MITANI K CHIBA S YAZAKI Y HIRAI H
Citation: Y. Kanda et al., INCREASED SOLUBLE FAS-LIGAND IN SERA OF BONE-MARROW TRANSPLANT RECIPIENTS WITH ACUTE GRAFT-VERSUS-HOST DISEASE, Bone marrow transplantation, 22(8), 1998, pp. 751-754

Authors: CARLENS S RINGDEN O REMBERGER M LONNQVIST B HAGGLUND H KLAESSON S MATTSSON J SVAHN BM WINIARSKI J LJUNGMAN P ASCHAN J
Citation: S. Carlens et al., RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS, Bone marrow transplantation, 22(8), 1998, pp. 755-761

Authors: LOWENTHAL RM FABERES C MARIT G BOIRON JM CONYMAKHOUL P PIGNEUX A AGAPE P VEZON G BOUZGAROU R DAZEY B FIZET D BERNARD P LACOMBE F REIFFERS J
Citation: Rm. Lowenthal et al., FACTORS INFLUENCING HEMATOPOIETIC RECOVERY FOLLOWING CHEMOTHERAPY-MOBILIZED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FORHEMATOLOGICAL MALIGNANCIES - A RETROSPECTIVE ANALYSIS OF A 10-YEAR SINGLE INSTITUTION EXPERIENCE, Bone marrow transplantation, 22(8), 1998, pp. 763-770

Authors: HILDEBRANDT M BLASER F BEYER J SIEGERT W MAPARA MY HUHN D SALAMA A
Citation: M. Hildebrandt et al., DETECTION OF TUMOR-CELLS IN PERIPHERAL-BLOOD SAMPLES FROM PATIENTS WITH GERM-CELL TUMORS USING IMMUNOCYTOCHEMICAL AND REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION TECHNIQUES, Bone marrow transplantation, 22(8), 1998, pp. 771-775
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>